Highlights Atropine combined with orthokeratology (ortho-k) is more effective than monotherapy in treating myopia in children aged 8-12. Ortho-k monotherapy might be more beneficial in younger children. This Journal Watch summarizes the study entitled “ Effect of atropine, orthokeratology and combined treatments for myopia control: A 2-year stratified randomised clinical trial ,” published in Br J Ophthalmol , 2022 .
1 ##Need of the study## Age is a crucial factor linked to poor efficacy outcomes of ortho-k and atropine efficacy, 2 and studies with aga-stratified randomized design to compare the effectiveness of atropine, ortho-k, and combined treatment are lacking. 3 The age-stratified design can produce concrete evidence of how age impacts these interventions, which can help clinicians choose suitable interventions for myopia control. Additionally, there is a paucity of long-term…
